Dr. Merilin Al Sharif | Publications

Home | CV | Publications | Citations


Selected publications

PhD Thesis

Publications in international and national scientific journals

  1. Odjakova, M., Popova, E., Al Sharif, M., Mironova, R.. „Plant-Derived Agents with Anti-Glycation Activity, Glycosylation”, in “Glycosylation”, Dr. Stefana Petrescu (Ed.), InTech, 2012, 223-256 (ISBN: 978-953-51-0771-2; DOI: 10.5772/48186). 2012, DOI:10.5772/48186, 223-256
  2. Al Sharif, M., Alov, P., Cronin, M., Fioravanzo, E., Tsakovska, I., Vitcheva, V., Worth, A., Yang, C., Pajeva, I.. Toward better understanding of liver steatosis MoA: Molecular modelling study of PPAR gamma receptor. Toxicology Letters, 221, Elsevier, 2013, ISSN:0378-4274, DOI:10.1016/j.toxlet.2013.05.099, S85-S85. ISI IF: 3.355 (2013), Q2
  3. Al Sharif, M., Alov, P., Vitchevap, V., Pajeva, I., Tsakovska, I.. Modes-of-action related to repeated dose toxicity: tissue-specific biological roles of PPARγ ligand-dependent dysregulation in nonalcoholic fatty liver disease. PPAR Research, 2014, 2014, ISSN:1687-4765, DOI:10.1155/2014/432647, ISI IF: 2.509 (2014), Q2
  4. Tsakovska, I., Al Sharif, M., Alov, P., Diukendjieva, A., Fioravanzo, E., Cronin, M.T.D., Pajeva, I.. Molecular modelling study of the PPARγ receptor in relation to the mode of action/adverse outcome pathway framework for liver steatosis. International Journal of Molecular Sciences, 15, 5, MDPI AG, BASEL, SWITZERLAND, 2014, ISSN:1422-0067, DOI:10.3390/ijms15057651, 7651-7666. ISI IF: 2.862 (2014), Q2
  5. Al Sharif, M., Alov, P., Tsakovska, I., Pajeva, I.. In silico modelling of full PPARγ agonists: a step towards liver steatosis risk assessment. Series G. Medicine, Pharmacy and Dental medicine, XVII, 2015, ISSN:1311-9427, 182-186
  6. Fratev, F., Tsakovska, I., Al Sharif, M., Mihaylova, E., Pajeva, I.. Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent Antagonists. International Journal of Molecular Sciences, 16, 7, 2015, ISSN:1422-0067, 15405-15424. ISI IF: 3.257 (2015), Q2
  7. Vitcheva, V., Mostrag-Szlichtyng, A., Sacher, O., Bienfait, B., Schwab, C.H., Richarz, A.-N., Tsakovska, I., Al Sharif, M., Pajeva, I., Yang, C.. In vivo data mining and in silico metabolic profiling to predict diverse hepatotoxic phenotypes: Case study of piperonyl butoxide. Toxicology Letters, 238, 2, supplement, Elsevier B.V., 2015, ISSN:0378-4274, DOI:10.1016/j.toxlet.2015.08.586, S173-S173. ISI IF: 3.522 (2015), Q1
  8. Al Sharif, M., Alov, P., Vitcheva, V., Diukendjieva, A., Mori, M., Botta, B., Tsakovska, I., Pajeva, I.. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction. Toxicol Appl Pharmacol, 337, Elsevier, 2017, ISSN:0041-008X, DOI:10.1016/j.taap.2017.10.013, 45-66. ISI IF: 3.616 (2017), Q1
  9. Al Sharif, M., Tsakovska, I., Pajeva, I., Alov, P., Fioravanzo, E., Bassan, A., Kovarich, S., Yang, C., Mostrag-Szlichtyng, A., Vitcheva, V., Worth, A.P., Richarz, A.N., Cronin, M.T.D.. The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation. Toxicology, Elsevier, 2017, ISSN:0300-483X, DOI:10.1016/j.tox.2016.01.009, ISI IF: 3.265 (2017), Q2
  10. Diukendjieva, A., Al Sharif, M., Alov, P., Pencheva, T., Tsakovska, I., Pajeva, I.. ADME/Tox Properties and Biochemical interactions of Silybin Congeners: In Silico Study. Natural Product Communications, 12, 2, 2017, ISSN:1555-9475, 175-178. ISI IF: 0.809 (2017), Q4
  11. Tsakovska, I., Pajeva, I., Al Sharif, M., Alov, P., Fioravanzo, E., Kovarich, S., Worth, A.P., Richarz, A.-N., Yang, C., Mostrag-Szlichtyng, A., Cronin, M.T.D.. Quantitative structure-skin permeability relationships. Toxicology, 387, Elsevier B.V., 2017, ISSN:0300-483X, DOI:10.1016/j.tox.2017.06.008, 27-42. ISI IF: 3.265 (2017), Q2
  12. Al Sharif, M., Alov, P., Diukendjieva, A., Vitcheva, V., Simeonova, R., Krasteva, I., Shkondrov, A., Tsakovska, I., Pajeva, I.. Molecular determinants of PPARγ partial agonism and related in silico / in vivo studies of natural saponins as potential type 2 diabetes modulators. Food Chem Toxicol, 112, Elsevier, 2018, ISSN:0278-6915, DOI:10.1016/j.fct.2017.12.009, 47-59. ISI IF: 3.775 (2018), Q1
  13. Al Sharif, M., Diukendjieva, A., Alov, P., Tsakovska, I., Pajeva, I.. Optimized Structure-based Methodology for Studying PPARγ Partial Agonists. Int J Bioautomation, 22, 1, BAS, Institute of Biophysics and Biomedical Engineering, 2018, ISSN:1314-2321, DOI:10.7546/ijba.2018.22.1.65-72, 65-72. SJR:0.25
  14. Diukendjieva, A., Al Sharif, M., Tsakovska, I., Pencheva, T., Alov, P., Pajeva, I.. In silico study of natural compounds: prediction of metabolism, toxicity and biochemical interactions. Proceedings of the Humboldt Kolleg: SCIENTIFIC REPORTS, Faber Publishing House, 2018, ISBN:978-619-00-0827-9, 24-33
  15. Пъжева, И., Цаковска, И., Пенчева, Т., Ал Шариф, М., Лесигярска, И, Фратев, Ф., Жерева, Д., Дюкенджиева, А.. IN SILICO ИЗСЛЕДВАНИЯ НА БИОЛОГИЧНО АКТИВНИ МОЛЕКУЛИ. Списание на БАН, CXXVI, 4, Издателство “Марин Дринов”, 2018, ISSN:0007-3989, 3-10
  16. Al Sharif, M., Vitcheva, V., Simeonova, R., Krasteva, I., Manov, V., Alov, P., Popov, G., Shkondrov, A., Pajeva, I.. In silico and in vivo studies of Astragalus glycyphylloides saponin(s) with relevance to metabolic syndrome modulation. Food Chem Toxicol, 130, Elsevier, 2019, ISSN:0278-6915, DOI:10.1016/j.fct.2019.05.032, 317-325. ISI IF: 3.775 (2018), Q1

Comments are closed.